Summary

The global Specialty Drug Distribution Market is set to experience remarkable growth, expanding from an estimated $4.1 billion in 2026 to $10.6 billion by 2033, at a robust CAGR of 14.6%. Specialty drugs, which include high-cost and complex medications for chronic, rare, or serious conditions, have become central to modern healthcare. The distribution of these therapies requires specialized logistics, regulatory compliance, and deep coordination between manufacturers, pharmacies, and healthcare providers.

The market is witnessing significant momentum as the prevalence of chronic diseases, oncology cases, autoimmune disorders, and rare conditions continues to rise globally. Efficient and reliable distribution networks are essential to ensure timely delivery, maintain drug integrity, and improve patient outcomes, driving the growth of this specialized segment of the pharmaceutical supply chain.

Market Insights

The specialty drug distribution market is evolving rapidly, with a noticeable shift from traditional retail pharmacies to integrated and technology-driven specialty distribution models. Companies are increasingly adopting cold-chain logistics, real-time tracking, inventory management software, and predictive analytics to streamline operations and minimize risk in handling sensitive therapies.

North America currently leads the market, supported by advanced healthcare infrastructure, widespread adoption of biologics, and strong reimbursement policies. Europe is experiencing steady growth, fueled by increasing healthcare spending, regulatory support for innovative treatments, and expansion of specialty pharmacy networks. Meanwhile, the Asia Pacific region offers immense opportunities, thanks to a large patient population, growing healthcare infrastructure, and rising awareness about advanced therapies.

The market is also benefiting from a surge in biologics, cell and gene therapies, and specialty generics. Personalized medicine and patient-centered care models are further enhancing demand for sophisticated distribution solutions. Collaboration between pharmaceutical manufacturers and distributors is becoming more strategic, enabling faster access to critical treatments and better patient outcomes.

Market Drivers

Several key factors are propelling the Specialty Drug Distribution Market:

1. Rising Prevalence of Chronic and Rare Diseases: Increasing cases of oncology, autoimmune, and rare disorders are boosting demand for specialty medications.

2. Innovations in Biologics and Advanced Therapies: The growth of high-value biologics, cell, and gene therapies has created the need for specialized logistics to maintain stability and efficacy.

3. Strict Regulatory and Storage Requirements: Specialty drugs often require controlled temperature and storage conditions, encouraging distributors to invest in advanced cold-chain solutions.

4. Focus on Patient-Centric Care: Home healthcare, patient support programs, and specialty pharmacies are becoming essential to ensure adherence, personalized care, and timely delivery.

5. Technology Integration: AI-driven supply chain management, digital platforms, and real-time monitoring are enhancing efficiency, reducing errors, and improving transparency in distribution.

Business Opportunities

The market presents substantial opportunities for distributors, logistics providers, and technology solution vendors. Rising demand for value-added services such as patient support, counseling, adherence monitoring, and home delivery is creating new revenue streams.

Emerging economies are particularly attractive for growth, driven by rising healthcare spending, expanding insurance coverage, and growing awareness of specialty therapies. Strategic partnerships with manufacturers, pharmacies, and healthcare providers can help distributors expand market reach and optimize supply chains.

Additionally, consolidation is shaping the competitive landscape. Mergers and acquisitions allow companies to enhance service offerings, expand geographic presence, and integrate advanced technologies. Distributors providing comprehensive, end-to-end specialty solutions are positioned to gain a significant market advantage.

Regional Analysis

• North America: The largest market due to widespread adoption of biologics, advanced therapies, and strong healthcare infrastructure.

• Europe: Growth supported by regulatory support for innovative treatments, healthcare expenditure, and expanding specialty pharmacy networks.

• Asia Pacific: High-growth region due to a large patient population, healthcare development initiatives, and increasing adoption of advanced therapies.

• Latin America: Emerging opportunities as healthcare infrastructure improves and awareness of specialty drugs increases.

• Middle East & Africa: Developing markets driven by government healthcare initiatives and increasing access to specialty medications.

Key Players

The Specialty Drug Distribution Market is highly competitive, with several global and regional players leading the landscape:

• AmerisourceBergen Corporation

• McKesson Corporation

• Cardinal Health, Inc.

• Cencora, Inc. (formerly part of AmerisourceBergen)

• Walgreens Boots Alliance

• CVS Health / CVS Specialty

• Drug Logistics, LLC

• Anda, Inc. (a subsidiary of Teva Pharmaceutical)

• H.D. Smith (now a division of AmerisourceBergen/Cencora)

• Smith Drug Company

• Morris & Dickson Co., LLC

• FFF Enterprises

• Kaléo, Inc.

• Besse Medical

• BioPlus Specialty Pharmacy

Market Segmentation

By Therapeutic Area

• Autoimmune & Inflammatory Diseases

• Infectious Diseases

• Neuroscience

• Oncology

• Rare Diseases

By Product Type

• Biologics

• Cell And Gene Therapies

• Small Molecule Drugs

• Specialty Generics

By Dosage Form

• Injectables

• Oral Solids

• Topicals

By Distribution Channel

• Alternative Channel

• Hospital Pharmacy

• Online Pharmacy

• Retail Pharmacy

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Speciality Drug Distribution Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Speciality Drug Distribution Market Outlook, 2020 - 2033
3.1. Global Speciality Drug Distribution Market Outlook, by Therapeutic Area, Value (US$ Bn), 2020-2033
3.1.1. Autoimmune & Inflammatory Diseases
3.1.2. Infectious Diseases
3.1.3. Neuroscience
3.1.4. Oncology
3.1.5. Rare Diseases
3.2. Global Speciality Drug Distribution Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
3.2.1. Biologics
3.2.2. Cell And Gene Therapies
3.2.3. Small Molecule Drugs
3.2.4. Specialty Generics
3.3. Global Speciality Drug Distribution Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
3.3.1. Injectables
3.3.2. Oral Solids
3.3.3. Topicals
3.4. Global Speciality Drug Distribution Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
3.4.1. Alternative Channel
3.4.2. Hospital Pharmacy
3.4.3. Online Pharmacy
3.4.4. Retail Pharmacy
3.5. Global Speciality Drug Distribution Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.5.1. North America
3.5.2. Europe
3.5.3. Asia Pacific
3.5.4. Latin America
3.5.5. Middle East & Africa
4. North America Speciality Drug Distribution Market Outlook, 2020 - 2033
4.1. North America Speciality Drug Distribution Market Outlook, by Therapeutic Area, Value (US$ Bn), 2020-2033
4.1.1. Autoimmune & Inflammatory Diseases
4.1.2. Infectious Diseases
4.1.3. Neuroscience
4.1.4. Oncology
4.1.5. Rare Diseases
4.2. North America Speciality Drug Distribution Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
4.2.1. Biologics
4.2.2. Cell And Gene Therapies
4.2.3. Small Molecule Drugs
4.2.4. Specialty Generics
4.3. North America Speciality Drug Distribution Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
4.3.1. Injectables
4.3.2. Oral Solids
4.3.3. Topicals
4.4. North America Speciality Drug Distribution Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
4.4.1. Alternative Channel
4.4.2. Hospital Pharmacy
4.4.3. Online Pharmacy
4.4.4. Retail Pharmacy
4.5. North America Speciality Drug Distribution Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.5.1. U.S. Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
4.5.2. U.S. Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
4.5.3. U.S. Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
4.5.4. U.S. Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
4.5.5. Canada Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
4.5.6. Canada Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
4.5.7. Canada Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
4.5.8. Canada Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Speciality Drug Distribution Market Outlook, 2020 - 2033
5.1. Europe Speciality Drug Distribution Market Outlook, by Therapeutic Area, Value (US$ Bn), 2020-2033
5.1.1. Autoimmune & Inflammatory Diseases
5.1.2. Infectious Diseases
5.1.3. Neuroscience
5.1.4. Oncology
5.1.5. Rare Diseases
5.2. Europe Speciality Drug Distribution Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
5.2.1. Biologics
5.2.2. Cell And Gene Therapies
5.2.3. Small Molecule Drugs
5.2.4. Specialty Generics
5.3. Europe Speciality Drug Distribution Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
5.3.1. Injectables
5.3.2. Oral Solids
5.3.3. Topicals
5.4. Europe Speciality Drug Distribution Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
5.4.1. Alternative Channel
5.4.2. Hospital Pharmacy
5.4.3. Online Pharmacy
5.4.4. Retail Pharmacy
5.5. Europe Speciality Drug Distribution Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.5.1. Germany Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
5.5.2. Germany Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
5.5.3. Germany Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
5.5.4. Germany Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
5.5.5. Italy Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
5.5.6. Italy Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
5.5.7. Italy Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
5.5.8. Italy Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
5.5.9. France Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
5.5.10. France Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
5.5.11. France Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
5.5.12. France Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
5.5.13. U.K. Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
5.5.14. U.K. Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
5.5.15. U.K. Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
5.5.16. U.K. Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
5.5.17. Spain Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
5.5.18. Spain Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
5.5.19. Spain Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
5.5.20. Spain Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
5.5.21. Russia Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
5.5.22. Russia Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
5.5.23. Russia Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
5.5.24. Russia Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
5.5.25. Rest of Europe Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
5.5.26. Rest of Europe Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
5.5.27. Rest of Europe Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
5.5.28. Rest of Europe Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Speciality Drug Distribution Market Outlook, 2020 - 2033
6.1. Asia Pacific Speciality Drug Distribution Market Outlook, by Therapeutic Area, Value (US$ Bn), 2020-2033
6.1.1. Autoimmune & Inflammatory Diseases
6.1.2. Infectious Diseases
6.1.3. Neuroscience
6.1.4. Oncology
6.1.5. Rare Diseases
6.2. Asia Pacific Speciality Drug Distribution Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
6.2.1. Biologics
6.2.2. Cell And Gene Therapies
6.2.3. Small Molecule Drugs
6.2.4. Specialty Generics
6.3. Asia Pacific Speciality Drug Distribution Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
6.3.1. Injectables
6.3.2. Oral Solids
6.3.3. Topicals
6.4. Asia Pacific Speciality Drug Distribution Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
6.4.1. Alternative Channel
6.4.2. Hospital Pharmacy
6.4.3. Online Pharmacy
6.4.4. Retail Pharmacy
6.5. Asia Pacific Speciality Drug Distribution Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.5.1. China Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
6.5.2. China Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
6.5.3. China Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
6.5.4. China Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
6.5.5. Japan Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
6.5.6. Japan Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
6.5.7. Japan Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
6.5.8. Japan Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
6.5.9. South Korea Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
6.5.10. South Korea Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
6.5.11. South Korea Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
6.5.12. South Korea Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
6.5.13. India Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
6.5.14. India Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
6.5.15. India Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
6.5.16. India Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
6.5.17. Southeast Asia Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
6.5.18. Southeast Asia Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
6.5.19. Southeast Asia Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
6.5.20. Southeast Asia Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
6.5.21. Rest of SAO Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
6.5.22. Rest of SAO Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
6.5.23. Rest of SAO Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
6.5.24. Rest of SAO Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Speciality Drug Distribution Market Outlook, 2020 - 2033
7.1. Latin America Speciality Drug Distribution Market Outlook, by Therapeutic Area, Value (US$ Bn), 2020-2033
7.1.1. Autoimmune & Inflammatory Diseases
7.1.2. Infectious Diseases
7.1.3. Neuroscience
7.1.4. Oncology
7.1.5. Rare Diseases
7.2. Latin America Speciality Drug Distribution Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
7.2.1. Biologics
7.2.2. Cell And Gene Therapies
7.2.3. Small Molecule Drugs
7.2.4. Specialty Generics
7.3. Latin America Speciality Drug Distribution Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
7.3.1. Injectables
7.3.2. Oral Solids
7.3.3. Topicals
7.4. Latin America Speciality Drug Distribution Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
7.4.1. Alternative Channel
7.4.2. Hospital Pharmacy
7.4.3. Online Pharmacy
7.4.4. Retail Pharmacy
7.5. Latin America Speciality Drug Distribution Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.5.1. Brazil Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
7.5.2. Brazil Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
7.5.3. Brazil Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
7.5.4. Brazil Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
7.5.5. Mexico Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
7.5.6. Mexico Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
7.5.7. Mexico Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
7.5.8. Mexico Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
7.5.9. Argentina Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
7.5.10. Argentina Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
7.5.11. Argentina Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
7.5.12. Argentina Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
7.5.13. Rest of LATAM Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
7.5.14. Rest of LATAM Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
7.5.15. Rest of LATAM Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
7.5.16. Rest of LATAM Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Speciality Drug Distribution Market Outlook, 2020 - 2033
8.1. Middle East & Africa Speciality Drug Distribution Market Outlook, by Therapeutic Area, Value (US$ Bn), 2020-2033
8.1.1. Autoimmune & Inflammatory Diseases
8.1.2. Infectious Diseases
8.1.3. Neuroscience
8.1.4. Oncology
8.1.5. Rare Diseases
8.2. Middle East & Africa Speciality Drug Distribution Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
8.2.1. Biologics
8.2.2. Cell And Gene Therapies
8.2.3. Small Molecule Drugs
8.2.4. Specialty Generics
8.3. Middle East & Africa Speciality Drug Distribution Market Outlook, by Dosage Form, Value (US$ Bn), 2020-2033
8.3.1. Injectables
8.3.2. Oral Solids
8.3.3. Topicals
8.4. Middle East & Africa Speciality Drug Distribution Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
8.4.1. Alternative Channel
8.4.2. Hospital Pharmacy
8.4.3. Online Pharmacy
8.4.4. Retail Pharmacy
8.5. Middle East & Africa Speciality Drug Distribution Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.5.1. GCC Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
8.5.2. GCC Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
8.5.3. GCC Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
8.5.4. GCC Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
8.5.5. South Africa Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
8.5.6. South Africa Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
8.5.7. South Africa Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
8.5.8. South Africa Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
8.5.9. Egypt Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
8.5.10. Egypt Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
8.5.11. Egypt Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
8.5.12. Egypt Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
8.5.13. Nigeria Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
8.5.14. Nigeria Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
8.5.15. Nigeria Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
8.5.16. Nigeria Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
8.5.17. Rest of Middle East Speciality Drug Distribution Market Outlook, by Therapeutic Area, 2020-2033
8.5.18. Rest of Middle East Speciality Drug Distribution Market Outlook, by Product Type, 2020-2033
8.5.19. Rest of Middle East Speciality Drug Distribution Market Outlook, by Dosage Form, 2020-2033
8.5.20. Rest of Middle East Speciality Drug Distribution Market Outlook, by Distribution Channel, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. AmerisourceBergen Corporation
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. McKesson Corporation
9.4.3. Cardinal Health, Inc.
9.4.4. Cencora, Inc. (formerly part of AmerisourceBergen)
9.4.5. Walgreens Boots Alliance
9.4.6. CVS Health / CVS Specialty
9.4.7. Drug Logistics, LLC
9.4.8. Anda, Inc. (a subsidiary of Teva Pharmaceutical)
9.4.9. H.D. Smith (now a division of AmerisourceBergen/Cencora)
9.4.10. Smith Drug Company
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations